Amgen

VECTIBIX

Manufacturer:

Amgen

Vectibix HCPCS:

J9303

HCPCS Code Descriptor:

Injection, panitumumab, 10 mg

Category:

J Code

Vectibix NDCs:

55513-0956-01, 55513-0954-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Vectibix:

VECTIBIX is an Oncology drug manufactured by Amgen and administered via the Intravenous route of administration. The J Code: J9303 is aligned to the drug VECTIBIX.

ACCESS PRICING AND MORE BY REGISTERING

J9303 Added Date:

January 1, 2008

J9303 Effective Date:

January 1, 2008

J9303 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Vectibix billing and coding information.
Vectibix patient assistance information can be found through Amgen Assist at the URL: https://www.amgenassist.com/copay
VECTIBIX prescribing information can be found at the link below:
Information regarding VECTIBIX’s side effects can be found at MedlinePlus